Memantine, an NMDAR antagonist, increases 20S proteasome activity, clearing aggregation-prone proteins like p21, p27, p-Tau, and beta amyloid precursors, restoring neurogenesis in AD mouse models [94]. This evidence concerns the gene MAPT and Alzheimer disease.